Which therapy helps kids with rare COVID-Linked syndrome recover fastest?
NCT ID NCT04898231
First seen Nov 04, 2025 · Last updated May 15, 2026 · Updated 41 times
Summary
This study looked at 73 children with MIS-C, a rare inflammatory condition linked to COVID-19. Researchers compared three treatments—infliximab, anakinra, and steroids—to see which one helped children recover fastest with the fewest side effects. The goal was to find the best initial therapy to reduce the need for additional anti-inflammatory drugs within the first week.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTISYSTEM INFLAMMATORY SYNDROME-CHILDREN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital Michigan
Detroit, Michigan, 48201, United States
-
Rady Children's Hospital
San Diego, California, 92123, United States
Conditions
Explore the condition pages connected to this study.